Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 88, Issue 5, 2013, Pages 347-353

  Huang, Li Li ^a,b   Wan, Jian Bo ^a,c   Wang, Bin ^a   He, Cheng Wei ^a,c   Ma, Huan ^a   Li, Tian Wang ^a   Kang, Jing X ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c University of Macau   (Macao)

Author keywords

Alcoholic liver disease; Docosahexaenoic acid; Hepatic steatosis; Inflammatory cytokines; Stearoyl CoA desaturase 1

Indexed keywords

ACYL COENZYME A DESATURASE 1; ALANINE AMINOTRANSFERASE; ALCOHOL; DOCOSAHEXAENOIC ACID; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOLIC FATTY LIVER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; ENZYME ACTIVITY; FATTY ACID ANALYSIS; HISTOPATHOLOGY; LIPID COMPOSITION; LIPID STORAGE; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA; MUS;

EID: 84877588714     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.02.002     Document Type: Article

References (44)

1. Mann R.E., Smart R.G., Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res. Health 2003, 27:209-219.
2. Bataller R., Brenner D.A. Liver fibrosis. J. Clin. Invest. 2005, 115:209-218.
3. Day C.P., James O.F. Hepatic steatosis: innocent bystander or guilty party?. Hepatology 1998, 27:1463-1466.
4. Johnson S.B., Gordon E., McClain C., Low G., Holman R.T. Abnormal polyunsaturated fatty acid patterns of serum lipids in alcoholism and cirrhosis: arachidonic acid deficiency in cirrhosis. Proc. Nat. Acad. Sci. USA 1985, 82:1815-1818.
5. Cabre E., Abad-Lacruz A., Nunez M.C., Gonzalez-Huix F., Fernandez-Banares F., Gil A., Esteve-Comas M., Moreno J., Planas R., Guilera M., et al. The relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis: multivariate analysis. Am. J. Gastroenterol. 1993, 88:718-722.
6. Xu J., Nakamura M.T., Cho H.P., Clarke S.D. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. J. Biol. Chem. 1999, 274:23577-23583.
7. Clarke S.D. Nonalcoholic steatosis and steatohepatitis I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281:G865-869.
8. Wada S., Yamazaki T., Kawano Y., Miura S., Ezaki O. Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice. J. Hepatol. 2008, 49:441-450.
9. Song B.J., Moon K.H., Olsson N.U., Salem N. Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. J. Hepatol. 2008, 49:262-273.
10. Sachan D.S., Yatim A.M., Daily J.W. Comparative effects of dietary corn oil, safflower oil, fish oil and palm oil on metabolism of ethanol and carnitine in the rat. J. Am. Coll. Nutr. 2002, 21:233-238.
11. Nanji A.A., Zhao S., Sadrzadeh S.M., Dannenberg A.J., Tahan S.R., Waxman D.J. Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats. Alcohol Clin. Exp. Res. 1994, 18:1280-1285.
12. Donohue T.M., Curry-McCoy T.V., Nanji A.A., Kharbanda K.K., Osna N.A., Radio S.J., Todero S.L., White R.L., Casey C.A. Lysosomal leakage and lack of adaptation of hepatoprotective enzyme contribute to enhanced susceptibility to ethanol-induced liver injury in female rats. Alcohol Clin. Exp. Res. 2007, 31:1944-1952.
13. Nanji A.A., Sadrzadeh S.M., Yang E.K., Fogt F., Meydani M., Dannenberg A.J. Dietary saturated fatty acids: a novel treatment for alcoholic liver disease. Gastroenterology 1995, 109:547-554.
14. Sekiya M., Yahagi N., Matsuzaka T., Najima Y., Nakakuki M., Nagai R., Ishibashi S., Osuga J., Yamada N., Shimano H. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003, 38:1529-1539.
15. Kelly F.J. The metabolic role of n-3 polyunsaturated fatty acids: relationship to human disease. Comp. Biochem. Physiol. A Comp. Physiol. 1991, 98:581-585.
16. Thurman R.G., Bradford B.U., Iimuro Y., Knecht K.T., Arteel G.E., Yin M., Connor H.D., Wall C., Raleigh J.A., Frankenberg M.V., Adachi Y., Forman D.T., Brenner D., Kadiiska M., Mason R.P. The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury. J. Gastroenterol. Hepatol. 1998, 13(Suppl.):S39-S50.
17. Carson E.J., Pruett S.B. Development and characterization of a binge drinking model in mice for evaluation of the immunological effects of ethanol. Alcohol Clin. Exp. Res. 1996, 20:132-138.
18. Pachikian B.D., Neyrinck A.M., Cani P.D., Portois L., Deldicque L., De Backer F.C., Bindels L.B., Sohet F.M., Malaisse W.J., Francaux M., Carpentier Y.A., Delzenne N.M. Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition. BMC Physiol. 2008, 8. , article no. 21.
19. Sherman K.E. Alanine aminotransferase in clinical practice. A review. Arch. Intern. Med. 1991, 151:260-265.
20. Kang J.X., Wang J. A simplified method for analysis of polyunsaturated fatty acids. BMC Biochem. 2005, 6:5.
21. Bao F., Dekaban G.A., Weaver L.C. Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats. J. Neurochem. 2005, 94:1361-1373.
22. Purohit V., Russo D., Coates P.M. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium. Alcohol 2004, 34:3-8.
23. Kaiser J.P., Beier J.I., Zhang J., David Hoetker J., von Montfort C., Guo L., Zheng Y., Monia B.P., Bhatnagar A., Arteel G.E. PKCepsilon plays a causal role in acute ethanol-induced steatosis. Arch. Biochem. Biophys. 2009, 482:104-111.
24. Ntambi J.M., Miyazaki M. Regulation of stearoyl-CoA desaturases and role in metabolism. Prog. Lipid Res. 2004, 43:91-104.
25. Attie A.D., Krauss R.M., Gray-Keller M.P., Brownlie A., Miyazaki M., Kastelein J.J., Lusis A.J., Stalenhoef A.F., Stoehr J.P., Hayden M.R., Ntambi J.M. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J. Lipid Res. 2002, 43:1899-1907.
26. Miyazaki M., Kim Y.C., Ntambi J.M. A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. J. Lipid Res. 2001, 42:1018-1024.
27. Cohen P., Miyazaki M., Socci N.D., Hagge-Greenberg A., Liedtke W., Soukas A.A., Sharma R., Hudgins L.C., Ntambi J.M., Friedman J.M. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002, 297:240-243.
28. Miyazaki M., Dobrzyn A., Sampath H., Lee S.H., Man W.C., Chu K., Peters J.M., Gonzalez F.J., Ntambi J.M. Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha. J. Biol. Chem. 2004, 279:35017-35024.
29. Peter A., Cegan A., Wagner S., Elcnerova M., Konigsrainer A., Konigsrainer I., Haring H.U., Schleicher E.D., Stefan N. Relationships between hepatic stearoyl-CoA desaturase 1 activity and mRNA expression with liver fat content in humans. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E321-326.
30. Yasari S., Prud'homme D., Wang D., Jankowski M., Levy E., Gutkowska J., Lavoie J.M. Exercise training decreases hepatic SCD-1 gene expression and protein content in rats. Mol. Cell. Biochem. 2010, 335:291-299.
31. De Minicis S., Brenner D.A. Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex. J. Gastroenterol. Hepatol. 2008, 23(Suppl. 1):S98-S103.
32. Wu D., Cederbaum A.I. Oxidative stress and alcoholic liver disease. Semin. Liver Dis. 2009, 29:141-154.
33. Zuniga J., Venegas F., Villarreal M., Nunez D., Chandia M., Valenzuela R., Tapia G., Varela P., Videla L.A., Fernandez V. Protection against in vivo liver ischemia-reperfusion injury by n-3 long-chain polyunsaturated fatty acids in the rat. Free Radical Res. 2010, 44:854-863.
34. Bouzidi N., Mekki K., Boukaddoum A., Dida N., Kaddous A., Bouchenak M. Effects of omega-3 polyunsaturated fatty-acid supplementation on redox status in chronic renal failure patients with dyslipidemia. J. Renal Nutr. 2010, 20:321-328.
35. Casos K., Zaragoza M.C., Zarkovic N., Zarkovic K., Andrisic L., Portero-Otin M., Cacabelos D., Mitjavila M.T. A fish-oil-rich diet reduces vascular oxidative stress in apoE(-/-) mice. Free Radical Res. 2010, 44:821-829.
36. Cosar M., Songur A., Sahin O., Uz E., Yilmaz R., Yagmurca M., Ozen O.A. The neuroprotective effect of fish n-3 fatty acids in the hippocampus of diabetic rats. Nutr. Neurosci. 2008, 11:161-166.
37. Slebos D.J., Ryter S.W., Choi A.M. Heme oxygenase-1 and carbon monoxide in pulmonary medicine. Respir. Res. 2003, 4:7.
38. Neuman M.G. Cytokines-central factors in alcoholic liver disease. Alcohol Res. Health 2003, 27:307-316.
39. Endo M., Masaki T., Seike M., Yoshimatsu H. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp. Biol. Med. 2007, 232:614-621.
40. Lawler J.F., Yin M., Diehl A.M., Roberts E., Chatterjee S. Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J. Biol. Chem. 1998, 273:5053-5059.
41. Yoon S.J., Koh E.J., Kim C.S., Zee O.P., Kwak J.H., Jeong W.J., Kim J.H., Lee S.M. Agrimonia eupatoria protects against chronic ethanol-induced liver injury in rats. Food Chem. Toxicol. 2012, 50:2335-2341.
42. Hill D.B., Marsano L., Cohen D., Allen J., Shedlofsky S., McClain C.J. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J. Lab Clin. Med. 1992, 119:547-552.
43. El-Assal O., Hong F., Kim W.H., Radaeva S., Gao B. IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver. Cell. Mol. Immunol. 2004, 1:205-211.
44. Hong F., Radaeva S., Pan H.N., Tian Z., Veech R., Gao B. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 2004, 40:933-941.